ICIs联合TKIs治疗HBV相关肝细胞癌患者疗效研究*
于双杰, 李元元, 毕京峰, 福军亮, 宓余强
Should the patients with advanced hepatocellular carcinoma get benefits from immunocheckpoint inhibitors and tyrosine kinase inhibitor combination therapy?
Yu Shuangjie, Li Yuanyuan, Bi Jingfeng, et al
实用肝脏病杂志
.
2023, (6): 891
-894
.
DOI: 10.3969/j.issn.1672-5069.2023.06.031
